# PMDA（医药品医疗器械综合机构）

医药品医疗器械综合机构（PMDA）是日本厚生劳动省（MHLW）下属的独立行政机构，负责医药品、医疗器械、再生医疗制品及相关健康产品的科学评估与安全监管。

视频指南

## 日本PMDA：器械路径与审评时限

英语音频 · 1:43

关于日本PMDA、器械分类、备案、认证、厚生劳动省审批及审评时限的视频指南。

[打开视频专页](https://www.pureglobal.com/zh/videos/what-is-japan-pmda-device-routes-and-review-times)

文字稿（英语）

What is Japan's PMDA? Since 2004, it has reviewed medicines and medical devices, and tracked their safety after they launch. But it does not grant the approval. PMDA publishes its review clock, and how it performs. In fiscal year 2025, its scorecard covered 38 new medical devices approved on standard review. 34 of them were approved within its target: 14 months from application. The route depends on the class. Class I is a notification to PMDA. Class II and III devices with certification standards go to a registered certification body. The rest, and every Class IV device, need ministry approval after PMDA review. And one point that often gets mixed up. PMDA does the scientific review and the safety monitoring. The approval decision belongs to the Ministry of Health, Labour and Welfare. Start with three things. One: confirm your device class and its route. Two: appoint a marketing authorization holder based in Japan. Three: prepare the application forms in Japanese, not English. Pick the route before the dossier. Pure Global covers registration, in-country representation, quality systems, audits and cybersecurity, in more than 30 markets. Visit pureglobal.com.

什么是日本PMDA？

最后审核日期: 2026年7月24日

独立行政法人医药品医疗器械综合机构（PMDA）是日本针对在[日本](https://www.pureglobal.com/zh/markets/japan)受监管的医药品、医疗器械及其他健康产品设立的科学审评与安全管理机构。该机构与[厚生劳动省（MHLW）](https://www.pureglobal.com/zh/glossary/japan-mhlw)紧密合作，通过对健康产品进行科学评估、持续监管和法规执法，在公共卫生领域发挥着核心作用。

虽然MHLW负责核发产品批准，但PMDA负责开展支持产品批准的技术与科学评估，以及上市后安全监测。该机构在产品上市前开展严格的科学评估，以确认产品符合既定标准。它还监督上市后监管，监测不良事件、召回和新出现的安全隐患，以确保产品在整个生命周期内保持安全。

## PMDA成立于何时？

PMDA根据《独立行政法人医药品医疗器械综合机构法》，于2004年4月1日成立。

## PMDA是否收取费用？

是的。PMDA对批准审评、QMS符合性评估和正式咨询收取费用。并非所有 II 类或 III 类器械都遵循PMDA批准审评：认证标准覆盖的器械可由注册认证机构进行认证，而其他 II 类和 III 类器械以及 IV 类器械则需要由PMDA审评支持的MHLW批准。请核查具体器械的当前途径与收费类别。

## PMDA支持何种监管框架？

日本的主要医疗器械法律是《医药品与医疗器械等品质、有效性及安全性确保法》（通常称为 PMD Act）。MHLW省令第169号确立了医疗器械质量管理体系要求。有关职责分工及按分类划分的途径，请参阅PMDA的[官方批准与认证概述](https://www.pmda.go.jp/english/review-services/reviews/0004.html)。

## 如何联系PMDA？

PMDA的英文[联系表单](https://www.pmda.go.jp/english/0002.html)是与其联系的最佳方式。该机构通常需要约15个工作日给予回复。

![独立行政法人医药品医疗器械综合机构](https://www.pureglobal.com/assets/owned/792c820a47--67ab304f89cb5422fdc63bec__68e6937adb7abd78891b03aa_000253405.png)

**网站：** [PMDA](https://www.pmda.go.jp/english/index.html)  
**地址：** 日本东京都千代田区霞关3-3-2新霞关大楼 100-0013  
**电子邮箱：** [联系表单](https://www.pmda.go.jp/english/0002.html)

[Canonical page](https://www.pureglobal.com/zh/glossary/japan-pmda)
